Biogen Eisai's Leqembi Alzheimer's drug rejected by EU regulator
European drug regulators on Friday rejected Leqembi's Alzheimer's treatment Biogen and Eisaicreating another hurdle for companies as they struggle to…
Biotechnology
Bristol Myers Squibb (BMY) Q2 2024 Results
Bristol Myers Squibb's research and development center at Cambridge Crossing in Cambridge, Massachusetts, on December 27, 2023. Adam Glanzman |…
Viking Therapeutics shares rise on plans to test weight-loss injection
Weight loss drug concept. Cr | Istock | Getty Images Actions of Viking Therapeutics rose more than 20% on Thursday…
Pfizer's gene therapy for hemophilia A successfully passes late-stage trials
Kena Betancur | Corbis News | Getty Images Pfizer On Wednesday, the US drugmaker announced that its experimental gene therapy…
Lawmakers unveil PBM reform bill amid rising drug costs
Fever on the surface | Getty Images Bipartisan lawmakers on Tuesday introduced a new bill that aims to crack down…
Pfizer's slimming pill advances as a once-daily version
Soup Images | Lightrocket | Getty Images Pfizer On Thursday it announced it will move ahead with a once-daily version…
FTC to sue PBMs over drug prices, including insulin
FTC Chair Lina Khan testifies during the House Appropriations Subcommittee on Financial Services and General Government hearing titled “Fiscal Year…
Novo Nordisk weight-loss drugs linked to rare eye disease, study finds
A box of Ozempic and its contents on a table in Dudley, North Tyneside, Britain, October 31, 2023. George Frey…
FDA approves Eli Lilly's donanemab drug for Alzheimer's
A sign with the company logo sits outside the Eli Lilly and Company headquarters campus on March 17, 2024 in…
Walgreens (WBA) earnings in the third quarter of 2024
In an aerial view, a customer enters a Walgreens store on January 4, 2024 in San Pablo, California. Justin Sullivan…